跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 69,040 条关于
“patidegib gel 2%”
全部
69,040
临床试验
45,481
药物
7,807
机构
1,493
资讯
14,259
昨天
Sol-Gel Completes Phase 3 Trial of Patidegib Gel 2% for Facial Basal Cell Carcinomas in Gorlin Syndrome
去年
Sol-Gel Technologies Receives Nasdaq Extension to Regain Compliance
去年
Sol-Gel Technologies Advances SGT-610 for Gorlin Syndrome and SGT-210 for Darier Disease
去年
Sol-Gel Completes Phase 3 Enrollment for Gorlin Syndrome Treatment SGT-610, Targets $300M Peak Revenue
6个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
去年
Sol-Gel and Mayne Pharma Announce $16 Million Deal for EPSOLAY and TWYNEO Rights in the U.S.
去年
Basal Cell Neoplasm Drug Pipeline Expands with 22+ Companies Developing Novel Therapies
9个月前
Sol-Gel Discontinues SGT-210 Development for Darier Disease After Phase 1b Trial Fails to Show Efficacy
去年
Bimiralisib Gel Shows Promising Results in Phase 2 Trial for Actinic Keratosis
2年前
Hormonal Gel Shows Promise in Phase 2 Trial for Male Contraception
第 1 页,共 1426 页
上一页
下一页